BeStock  

AptarGroup ATR

US equityMarket cap rank #1511Medical Instruments & Supplies
$140.08 −$0.26 (-0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $140.08 0.00%
Open$142.35
Prev close$140.34
Day range$139.85 – $143.88
Volume868.1K
Market cap$8.88B
P/E (TTM)33.8
Dividend yield1.37%

ATR Stock News

Headlines matching AptarGroup or the ATR ticker, most recent first.

  • Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Raises Target Price to $155 PositiveMarket news · 3 Aug 2026 · Direct mention
  • BofA Securities Maintains AptarGroup(ATR.US) With Buy Rating, Maintains Target Price $172Market news · 21 Aug 2026 · Direct mention
  • BofA Securities Maintains AptarGroup(ATR.US) With Buy RatingMarket news · 1 Aug 2026 · Direct mention
  • Analysts' Opinions Are Mixed on These Healthcare Stocks: AptarGroup (ATR) and Contineum Therapeutics, Inc. Class A (CTNM)TipRanks · 31 Jul 2026 · Direct mention
  • William Blair Maintains AptarGroup(ATR.US) With Hold RatingMarket news · 31 Jul 2026 · Direct mention
  • Raymond James Maintains AptarGroup(ATR.US) With Buy Rating, Cuts Target Price to $160 NegativeMarket news · 15 Jul 2026 · Direct mention
  • BofA Securities Upgrades AptarGroup(ATR.US) to Buy Rating, Raises Target Price to $173 PositiveMarket news · 14 Jul 2026 · Direct mention
  • Astron Corp Ltd (Delisted): Application for quotation of securities - ATRASX · 2 Jun 2026 · Direct mention
  • Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Maintains Target Price $145Market news · 12 Jun 2026 · Direct mention
  • Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Raises Target Price to $145 PositiveMarket news · 4 May 2026 · Direct mention
  • Astron Corp Ltd (Delisted): Application for quotation of securities - ATRASX · 18 May 2026 · Direct mention
  • BofA Securities Maintains AptarGroup(ATR.US) With Hold Rating, Cuts Target Price to $145 NegativeMarket news · 6 Apr 2026 · Direct mention
  • Astron Corp Ltd (Delisted): Application for quotation of securities - ATRASX · 1 Apr 2026 · Direct mention
  • CytoSorbents: Neutral Stance as U.S. DrugSorb-ATR Opportunity Offsets Near-Term Execution and Regulatory RisksTipRanks · 26 Mar 2026 · Direct mention
  • Wells Fargo Upgrades AptarGroup(ATR.US) to Buy Rating, Raises Target Price to $144 PositiveMarket news · 20 Mar 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ATR.

Sign in to join the discussion.

Scroll to Top